IFNB1 and breast cancer: Berberine, a purified compound of the crude extract of an anti-inflammatory herb coptis, remarkably upregulated IFN-β expression in a breast cancer cell line, thus demonstrating potential as a promising adjuvant for breast cancer treatment (24).